… The drug enhances slow inactivation of voltage-gated … Eslicarbazepine acetate has few, but
some, drug–drug … Clinical studies using eslicarbazepine acetate as adjunctive treatment or …

… Although data on teratogenicity is sparse with eslicarbazepine acetate, the other two …
and pain conditions, they are one of the most prescribed families of antiepileptic drugs. …

… drug belonging to the CBZ family and the active metabolite of OXC (structure [I] in Scheme
1). Eslicarbazepine acetate is a … tion be granted for the drug in the European Union under the …

… In general, following oral administration to animals or humans, no or minimal measurable
concentrations of the parent drug (eslicarbazepine acetate) were observed. In the rat, …

… family of antiepileptic drugs (AEDs), which includes carbamazepine (first generation) and
oxcarbazepine (second generation) (1,2). Eslicarbazepine acetate … , eslicarbazepine acetate is …

… and eslicarbazepine acetate (ESL) belong to the dibenzazepine family of antiepileptic drugs
… effectiveness and tolerability within the dibenzazepine family has emerged from studies in …

… Eslicarbazepine acetate (ESL) is a novel antiepileptic drug indicated for the treatment of
partial-onset seizures. Structurally, it belongs to the dibenzazepine family and is closely related …

… Objective: To evaluate the effectiveness of eslicarbazepine acetate (ESL) in the treatment
of … A direct contact with the drug manufacturer and developer was made. Results/conclusion: …

… is a is a once-daily antiepileptic drug (AED) that was approved in 2009 … family of AEDs with
distinctive mechanism of action, posology and tolerability profile. The eslicarbazepine acetate …

… Eslicarbazepine acetate (ESL) is a new antiepileptic drug whose mechanism of action is …
(ESL) is a third-generation member of the dibenzazepine family, which also includes …